RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas Article

Vogelbaum, MA, Berkey, B, Peereboom, D et al. (2005). RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas . JOURNAL OF CLINICAL ONCOLOGY, 23(16_suppl), 1520-1520. 10.1200/jco.2005.23.16_suppl.1520

cited authors

  • Vogelbaum, MA; Berkey, B; Peereboom, D; Giannini, C; Suh, J; Brown, P; Blumenthal, D; Biggs, C; Schultz, C; Mehta, M

authors

publication date

  • June 1, 2005

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 1520

end page

  • 1520

volume

  • 23

issue

  • 16_suppl